Acta Med. 2003, 46: 85-89

https://doi.org/10.14712/18059694.2019.12

Imatinib Mesylate (STI 571) – A New Oral Target Therapy For Chronic Myelogenous Leukemia (CML)

Ladislav Chrobák, Jaroslava Voglová

Charles University in Prague, Faculty of Medicine and University Hospital in Hradec Králové, 2nd Department of Medicine, Division of Clinical Hematology, Hradec Králové, Czech Republic

Received April 1, 2003
Accepted May 1, 2003

Individual author index pages


Other articles of these authors

front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive